Cargando…

Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression

Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with unsuppressed PRA; thus, these characteristics were...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubo, Haremaru, Tsurutani, Yuya, Inoue, Kosuke, Watanabe, Kazuki, Yamazaki, Yuto, Sunouchi, Takashi, Hoshino, Yoshitomo, Hirose, Rei, Katsuragawa, Sho, Tannai, Hiromitsu, Shibahara, Yukiko, Kakuta, Yukio, Matsui, Seishi, Saito, Jun, Omura, Masao, Sasano, Hironobu, Nishikawa, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049528/
https://www.ncbi.nlm.nih.gov/pubmed/35482752
http://dx.doi.org/10.1371/journal.pone.0267732
_version_ 1784696157811769344
author Kubo, Haremaru
Tsurutani, Yuya
Inoue, Kosuke
Watanabe, Kazuki
Yamazaki, Yuto
Sunouchi, Takashi
Hoshino, Yoshitomo
Hirose, Rei
Katsuragawa, Sho
Tannai, Hiromitsu
Shibahara, Yukiko
Kakuta, Yukio
Matsui, Seishi
Saito, Jun
Omura, Masao
Sasano, Hironobu
Nishikawa, Tetsuo
author_facet Kubo, Haremaru
Tsurutani, Yuya
Inoue, Kosuke
Watanabe, Kazuki
Yamazaki, Yuto
Sunouchi, Takashi
Hoshino, Yoshitomo
Hirose, Rei
Katsuragawa, Sho
Tannai, Hiromitsu
Shibahara, Yukiko
Kakuta, Yukio
Matsui, Seishi
Saito, Jun
Omura, Masao
Sasano, Hironobu
Nishikawa, Tetsuo
author_sort Kubo, Haremaru
collection PubMed
description Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with unsuppressed PRA; thus, these characteristics were examined herein. Nine patients with unsuppressed PRA and 86 patients with suppressed PRA were examined. All patients underwent segmental adrenal venous sampling (sAVS) and adrenalectomy, and were pathologically confirmed to have cytochrome P450 11B2 (CYP11B2)-positive aldosterone-producing adenoma according to international histopathology consensus criteria. Unsuppressed and suppressed PRA were defined as PRA levels of > 1.0 and ≤ 1.0 ng/mL/hr, respectively, in multiple blood samples obtained in the resting position. The unsuppressed PRA group had higher morning cortisol levels (12.6 [8.5, 13.5] vs. 8.5 [7.1, 11.0] μg/dL, P = 0.03) and higher cortisol levels after a 1 mg dexamethasone suppression test (DST) (2.2 [1.6, 2.5] vs. 1.3 [1.0, 1.9] μ g/dL, P = 0.004) than the suppressed PRA group. The unsuppressed PRA group also showed higher aldosterone levels on the non-surgical side during sAVS (P = 0.02 before adrenocorticotropic hormone (ACTH) stimulation, P = 0.002 after ACTH stimulation), a higher intensity of CYP17 expression in the resected adrenal gland (P = 0.02), and a lower clinical complete success rate 1 year after surgery (P = 0.04) compared with those in the suppressed PRA group. These findings suggest that PA should not be ruled out by unsuppressed PRA among patients with hypertension, particularly when their cortisol levels remain unsuppressed in the 1 mg DST. Meanwhile, it should be acknowledged that patients with unsuppressed PRA have higher aldosterone levels on the non-surgical side, and a lower likelihood of postoperative complete clinical success is to be expected.
format Online
Article
Text
id pubmed-9049528
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-90495282022-04-29 Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression Kubo, Haremaru Tsurutani, Yuya Inoue, Kosuke Watanabe, Kazuki Yamazaki, Yuto Sunouchi, Takashi Hoshino, Yoshitomo Hirose, Rei Katsuragawa, Sho Tannai, Hiromitsu Shibahara, Yukiko Kakuta, Yukio Matsui, Seishi Saito, Jun Omura, Masao Sasano, Hironobu Nishikawa, Tetsuo PLoS One Research Article Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with unsuppressed PRA; thus, these characteristics were examined herein. Nine patients with unsuppressed PRA and 86 patients with suppressed PRA were examined. All patients underwent segmental adrenal venous sampling (sAVS) and adrenalectomy, and were pathologically confirmed to have cytochrome P450 11B2 (CYP11B2)-positive aldosterone-producing adenoma according to international histopathology consensus criteria. Unsuppressed and suppressed PRA were defined as PRA levels of > 1.0 and ≤ 1.0 ng/mL/hr, respectively, in multiple blood samples obtained in the resting position. The unsuppressed PRA group had higher morning cortisol levels (12.6 [8.5, 13.5] vs. 8.5 [7.1, 11.0] μg/dL, P = 0.03) and higher cortisol levels after a 1 mg dexamethasone suppression test (DST) (2.2 [1.6, 2.5] vs. 1.3 [1.0, 1.9] μ g/dL, P = 0.004) than the suppressed PRA group. The unsuppressed PRA group also showed higher aldosterone levels on the non-surgical side during sAVS (P = 0.02 before adrenocorticotropic hormone (ACTH) stimulation, P = 0.002 after ACTH stimulation), a higher intensity of CYP17 expression in the resected adrenal gland (P = 0.02), and a lower clinical complete success rate 1 year after surgery (P = 0.04) compared with those in the suppressed PRA group. These findings suggest that PA should not be ruled out by unsuppressed PRA among patients with hypertension, particularly when their cortisol levels remain unsuppressed in the 1 mg DST. Meanwhile, it should be acknowledged that patients with unsuppressed PRA have higher aldosterone levels on the non-surgical side, and a lower likelihood of postoperative complete clinical success is to be expected. Public Library of Science 2022-04-28 /pmc/articles/PMC9049528/ /pubmed/35482752 http://dx.doi.org/10.1371/journal.pone.0267732 Text en © 2022 Kubo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kubo, Haremaru
Tsurutani, Yuya
Inoue, Kosuke
Watanabe, Kazuki
Yamazaki, Yuto
Sunouchi, Takashi
Hoshino, Yoshitomo
Hirose, Rei
Katsuragawa, Sho
Tannai, Hiromitsu
Shibahara, Yukiko
Kakuta, Yukio
Matsui, Seishi
Saito, Jun
Omura, Masao
Sasano, Hironobu
Nishikawa, Tetsuo
Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression
title Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression
title_full Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression
title_fullStr Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression
title_full_unstemmed Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression
title_short Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression
title_sort characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049528/
https://www.ncbi.nlm.nih.gov/pubmed/35482752
http://dx.doi.org/10.1371/journal.pone.0267732
work_keys_str_mv AT kuboharemaru characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT tsurutaniyuya characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT inouekosuke characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT watanabekazuki characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT yamazakiyuto characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT sunouchitakashi characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT hoshinoyoshitomo characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT hiroserei characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT katsuragawasho characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT tannaihiromitsu characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT shibaharayukiko characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT kakutayukio characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT matsuiseishi characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT saitojun characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT omuramasao characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT sasanohironobu characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression
AT nishikawatetsuo characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression